First China Pharmaceutical Group, Inc. Receivables Turnover Ratio (FCPG), from the third quarter 2012 to the third quarter 2011 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
First China Pharmaceutical Group, Inc.  (FCPG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

First China Pharmaceutical Group Accounts Receivables Turnover Ratio from the third quarter 2012 to the third quarter 2011

Quarterly Results, Trends, Rankings, Statistics


First China Pharmaceutical Group, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2012 to a ratio of 7.38, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the First China Pharmaceutical Group in Sep 30 2012 quarter, has decreased to 49 days, compared to 65 days, in the Jun 30 2012 quarter.

If we take a look into Healthcare sector 29 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2012 from 0 to 460.

What is Receivable Turnover Ratio?
What is First China Pharmaceutical Group, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FCPG Receivables Turnover Ratio (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Receivable Change -60.44 % 68.69 % 124.11 % 69.93 % -
Y / Y Revenue Change 49.42 % 90.02 % 70.91 % 98.12 % -
Receivable Turnover Ratio (TTM) 7.38 5.64 5.25 6.56 5.81
FCPG's Total Ranking # 460 # 0 # 0 # #
Accounts Receivable average collection period days 49 65 70 56 63
Seq. Receivable Change -34.83 % -69.2 % 346.37 % -55.84 % 177.88 %
Seq. Revenue Change 23.89 % 15.1 % -14.28 % 22.24 % 57.56 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 30
Overall Market # 460

Receivable Turnover Ratio Statistics
High Average Low
27.5 15.09 2.68
(Sep 30 2012)   (Mar 31 2012)





FCPG Company Profile • Back to FCPG Efficiency Comparisons • Compare FCPG Receivables Turnover Ratio to its Competitors

Financial Statements
First China Pharmaceutical Group's Accounts Receivable $ 4 Millions Visit FCPG's Balance sheet
First China Pharmaceutical Group's Sales TTM $ 58 Millions Visit FCPG's Income Statement
Sources of FCPG's Revenues Visit FCPG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FCPG's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FCPG's Growth Rates FCPG's Roa FCPG's Inventory Turnover Ratio FCPG's Dividend Comparisons
FCPG's Profitability Ratios FCPG's Roi FCPG's Asset Turnover Ratio FCPG's Dividend Growth
FCPG's Valuation Ratios FCPG's Roe FCPG's Financial Strength Ratios FCPG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2012 Receivable at quarter ending Sep 30 2012
Alaunos Therapeutics Inc   34.78 $ 0.800  Millions$ 0.023  Millions
Biora Therapeutics Inc   34.47 $ 0.173  Millions$ 0.005  Millions
Nature s Sunshine Products inc   33.92 $ 369.147  Millions$ 10.882  Millions
Alnylam Pharmaceuticals Inc   31.59 $ 78.685  Millions$ 2.491  Millions
Integrated Biopharma Inc  31.28 $ 54.707  Millions$ 1.749  Millions
Ernexa Therapeutics Inc   30.89 $ 24.235  Millions$ 0.785  Millions
Sangui Biotech International Inc  29.60 $ 0.004  Millions$ 0.000  Millions
Skinvisible Inc   28.25 $ 0.146  Millions$ 0.005  Millions
First China Pharmaceutical Group, Inc.  27.50 $ 57.830  Millions$ 2.103  Millions
Dyne Therapeutics Inc   26.62 $ 945.000  Millions$ 35.500  Millions
Brookdale Senior Living Inc   26.51 $ 2,742.788  Millions$ 103.447  Millions
Assertio Holdings inc   26.11 $ 76.359  Millions$ 2.925  Millions
Neurocrine Biosciences Inc   25.56 $ 42.303  Millions$ 1.655  Millions
Magellan Health inc   24.94 $ 3,098.587  Millions$ 124.242  Millions
Stablecoin Development Corporation  24.63 $ 7.063  Millions$ 0.287  Millions
Sunlink Health Systems Inc   23.76 $ 128.849  Millions$ 5.423  Millions
Cocrystal Pharma Inc   22.42 $ 25.868  Millions$ 1.154  Millions
Wearable Health Solutions, Inc.  21.83 $ 0.639  Millions$ 0.029  Millions
Durect Corp  21.28 $ 58.744  Millions$ 2.761  Millions
Vanda Pharmaceuticals Inc   20.77 $ 33.177  Millions$ 1.597  Millions
Grapefruit Usa Inc   20.45 $ 1.271  Millions$ 0.062  Millions
Inergetics Inc  20.44 $ 0.049  Millions$ 0.002  Millions
Oragenics Inc   19.39 $ 1.298  Millions$ 0.067  Millions
Shengtai Pharmaceutical, Inc.  18.79 $ 187.718  Millions$ 9.993  Millions
Protalix Biotherapeutics inc   18.61 $ 36.060  Millions$ 1.938  Millions
Musclepharm Corporation  17.23 $ 56.901  Millions$ 3.302  Millions
Incyte Corporation  17.03 $ 212.102  Millions$ 12.452  Millions
Aspira Women s Health inc   16.25 $ 1.820  Millions$ 0.112  Millions
Athersys Inc  16.11 $ 8.984  Millions$ 0.558  Millions
Therapeuticsmd Inc   15.33 $ 3.132  Millions$ 0.204  Millions

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.